Asia Pacific Wound Biologics Market Size & Outlook
Related Markets
Asia Pacific wound biologics market highlights
- The Asia Pacific wound biologics market generated a revenue of USD 372.3 million in 2023.
- The market is expected to grow at a CAGR of 7.9% from 2024 to 2030.
- In terms of segment, biological skin substitutes was the largest revenue generating type in 2023.
- Biological Skin Substitutes is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 372.3 million |
| Market revenue in 2030 | USD 628.0 million |
| Growth rate | 7.9% (CAGR from 2024 to 2030) |
| Largest segment | Biological skin substitutes |
| Fastest growing segment | Biological Skin Substitutes |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biological Skin Substitutes, Topical Agents, Collagen Dressing |
| Key market players worldwide | Molnlycke Health Care, Osiris Therapeutics, Integra LifeSciences, Wright Medical Group, Smith & Nephew PLC |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 16.0% of the global wound biologics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 628.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Wound Biologics Market Scope
Wound Biologics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Wright Medical Group | View profile | 1001-5000 | Arlington, Tennessee, United States, North America | http://www.wright.com/ |
| Osiris Therapeutics | View profile | 501-1000 | Columbia, Maryland, United States, North America | http://osiris.com |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | http://www.molnlycke.com/ |
| Integra LifeSciences | View profile | 5001-10000 | Princeton, New Jersey, United States, North America | http://www.integralife.com |
| Smith & Nephew PLC | View profile | 18452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | https://www.smith-nephew.com |
Asia Pacific wound biologics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to wound biologics market will help companies and investors design strategic landscapes.
Biological skin substitutes was the largest segment with a revenue share of 69.46% in 2023. Horizon Databook has segmented the Asia Pacific wound biologics market based on biological skin substitutes, topical agents, collagen dressing covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Asia Pacific wound biologics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific wound biologics market databook
-
Our clientele includes a mix of wound biologics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific wound biologics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific wound biologics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific wound biologics market size, by country, 2018-2030 (US$M)
Asia Pacific Wound Biologics Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
